EY Parthenon published a report titled 'From Volume to Value: Indian Pharma's Transformation with Data and AI' in partnership with the Government of Telangana at the BioAsia 2024. The report stressed the potential of how Generative AI can redefine...

India has risen as a pivotal contributor in this arena, providing distinct benefits that can be utilized to fast-track the creation and sanctioning of novel treatments.

The approach of precision medicine is designed for healthcare customization, with treatments being specifically designed to match the distinct genetic makeup, habits, and environmental exposures of each patient

As of 2023, over 800 hospitals in India have achieved NABH accreditation, reflecting a growing emphasis on quality healthcare. NABH accreditation is not just a prestigious certification but a comprehensive framework designed to enhance patient...

The Indian pharmaceutical industry is currently investing a lot into innovation in order to keep up with the global competition. Many companies are focusing on development of novel drug delivery systems.

A novel biomarker for alzheimer's disease in its asymptomatic phase has been discovered in a study that was conducted by the Molecular and Cellular Neurobiotechnology group at the University of Barcelona & the